Novartis India Limited (BOM:500672)
India · Delayed Price · Currency is INR 1,637.10
+22.15 (1.37%)
At close: Sep 4, 2026
Novartis India Market Cap
Novartis India has a market cap or net worth of 40.42 billion as of September 4, 2026. Its market cap has increased by 75.46% in one year.
Market Cap
40.42B
Enterprise Value
33.78B
Revenue
3.71B
Ranking
n/a
PE Ratio
41.34
Stock Price
1,637.10
ChartMarket Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 40.42B, an increase of 221.18%. That is a compound annual growth rate of 4.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 40.42B | 110.15% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi India | 72.55B |
| Bliss GVS Pharma | 71.07B |
| Morepen Laboratories | 62.30B |
| FDC Limited | 55.79B |
| Gufic Biosciences | 44.67B |
| Unichem Laboratories | 38.79B |
| Kwality Pharmaceuticals | 34.18B |
| Hikal | 27.40B |